Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene

Atherosclerosis

Volumn 128, Issue 2, 1997, Pages 165-174

  Knudsen, Petteri ^a   Antikainen, Marjatta ^b   Uusi Oukari, Mikko ^b   Ehnholm, Sonja ^b   Lahdenperä, Sanni ^a   Bensadoun, Andre ^c   Funke, Harald ^d   Wiebusch, Heiko ^d   Assmann, Gerd ^d   Taskinen, Marja Riitta ^a   Ehnholm, Christian ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Department of Obstetrics Gynecology   (United States)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

HDL cholesterol; hepatic lipase; mutation; triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HUMAN; LIVER; MALE; MUTAGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; GENES; HEPARIN; HETEROZYGOTE; HUMANS; LIPASE; LIPIDS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE;

EID: 0031052632     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05999-0     Document Type: Article

References (66)

1. Kinnunen PKJ, Virtanen A, Vainio P. Lipoprotein lipase and hepatic endothelial lipase: their roles in plasma lipoprotein metabolism. Atheroscler Rev 1983;11:65-105.
2. Ehnholm C, Kuusi T. Preparation, characterization and measurement of hepatic lipase. Methods Enzymol 1986;129:716-738.
3. Ehnholm C, Shaw W, Greten H, Brown WV. Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem 1975;250:6756-6761.
4. Taskinen M-R, Kuusi T. Enzymes involved in triglyceride metabolism. Bailliere's Clinical Endocrinol Metab 1987;1:639-666.
5. Bensadoun A, Berryman DE. Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol 1996; 7: 77-87.
6. Huttunen JK, Ehnholm C, Kekki M, Nikkilä EA. Postheparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridemia: correlations to age, sex and various parameters of triglyceride metabolism. Clin Sci Mol Med 1976;50:249-260.
7. Jansen H, van Tol A, Hülsmann WC. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun 1980;92:53-59.
8. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1993;4:187-196
9. 2. J Biol Chem 1994;269:11 572-11 577.
10. Clay MA, Newham HH, Forte TM, Barter PI. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992;1124:52-58.
11. Clay MA, Newham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler Thromb 1991;11:415-422.
12. Barter PJ, Liang H-Q, Clay MA, Rye K-A. Roles of hepatic lipase and cholesterol ester transfer protein in HDL metabolism. Atherosclerosis 1995;X:731-735.
13. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-B-migrating high-density lipoprotein. Biochemistry 1988;27:25-29.
14. Huang Y, von Eckardstein A, Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Atherioscler Thromb 1993;13:445-458.
15. Packard CJ. Plasma lipid and lipoprotein metabolism in the 1990s - what we know and what we need to know. In: Betteridge J. (ed). Lipids: Current Perspectives. London: Martin Dunitz, 1996;1-20.
16. Bamberger M, Lund-Katz S, Phillips MC, Rothblat GH. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. Biochemistry 1985;24:3693-3701.
17. Ji Z-S, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase secreting hepatoma cells in culture. J Biol Chem 1994;269:13 429-13 436.
18. Marques-Vidal P, Azema C, Collet X, Vieu C, Chap H, Perret B. Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res 1994;35:373-384.
19. Murase T, Itakura H. Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic lipase antibody in rats. Atherosclerosis 1981;39:293-300.
20. Goldberg IJ, Le N-A, Paterniti JR, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982;70:1184-1192.
21. Demant T, Carlsson LA, Holmquist L et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988;29:1603-1611.
22. Fan J, Wang J, Bensadoun A et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sei USA 1994;91:8724-8728.
23. Homanics GE, de Silva HV, Osada J et al. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995;270:2974-2980.
24. Daggy BP, Bensadoun A. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim Biophys Acta 1986;877:252-261.
25. Applebaum-Bowden D, Kobayashi J, Kashyap VS et al. Hepatic lipase gene therapy in hepatic lipase-deficient mice. J Clin Invest 1996;97:799-805.
26. Carlson LA, Holmquist L, Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alphatriglyceridemia. Acta Med Scand 1986;219:435-447.
27. Auwerx JH, Babirak SP, Hokanson JE et al. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet 1990;46:470-477.
28. Hegele RA, Vezina C, Moorjani S et al. A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J Clin Endocrin Metab 1991;72:730-732.
29. Hegele RA, Little JA, Vezina C et al. Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics. Arteriosler Thromb 1993;13:720-728.
30. Knudsen P, Antikainen M, Ehnholm S et al. A compound heterozygote for hepatic lipase gene mutations Leu334Phe and Thr383Met: correlation between HL activity and phenotypic expression. J Lipid Res 1996; 37: 825-834.
31. Cai S-J, Wong DM, Chen S-H, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989;28:8966-8971.
32. Datta S, Luo C-C, Li W-H et al. Human hepatic lipase. J Biol Chem 1988;263:1107-1110.
33. Durstenfeld A, Ben-Zeer O, Rene K, Stahnke G, Doolittle MH. Molecular characterization of human hepatic lipase deficiency. In vitro expression of two naturally occuring mutations. Arterioscler Thromb 1994;14:381-385.
34. Bensadoun A. Sandwich immunoassay for measurement of human hepatic lipase. Methods Enzymol. 1996;263:333-338.
35. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-350.
36. Beaucage SL, Caruthers MH. Deoxynucleotide phosphoramidites - a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett 1982;22:1859-1862.
37. Tenkanen H, Koskinen P, Baumann M et al. 1992. A novel polymorphism of apolipoprotein A-IV is the result of an aspargine to serine substitution at residue 127. Biochim Biophys Acta 1992;1138:27-33.
38. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-879.
39. Sanger F, Coulson AR, Barrel BG, Smith AHJ, Roe BA. Cloning in single stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol 1980;143:161-178.
40. Casanova J-L, Pannetier C, Jaulin C, Kourilsky P. Optimal conditions for directly sequencing doublestranded PCR products with Sequenase. Nucleic Acids Res 1990;18:4028.
41. Funke H, Assman G. Rapid molecular diagnosis of genetic cardiovascular risk factors. Curr Opin Lipidol 1993;4:453-460.
42. Syvänen AC, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990;8:684-692.
43. Bengström M, Jungell-Nortamo A, Syvänen A-C. Biotinylation of oligonucleotides using a water-soluble biotin ester. Nucleosides Nucleotides 1990;9:123-127.
44. Taylor JW, Ott J, Eckstein F. The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res 1985;13:8764-8785.
45. Felgner PL, Gedek TR, Holm M et al. Lipofection: a highly efficient lipid mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7417.
46. Tigman C, Melen K, Lundström K et al. Expression of recombinant soluble and membrane-bound catechol-O-methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain. Eur J Biochem 1992;207:813-821.
47. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
48. Syvänne M, Ahola M, Lahdenperä S et al. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 1995;36:573-582.
49. Röschlau P, Bernt E, Gruber E. Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Z Klin Chem Klin Biochem 1974;12:403-407.
50. Wahlefeld AW. Triglycerides. Determination after enzymatic hydrolysis. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis, 2nd edn. New York: Verlag-Chemie Weinheim, Academic Press 1974;1831-1835.
51. Kashyap MR, Hynd BA, Robinson K. A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. J Lipid Res 1980;21:491-495.
52. Ehnholm C, Lukka M, Kuusi T, Nikkilä EA, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
53. Wilson DE, Emi M, Iverius P-H et al. Phenotypic expression of heterozygous lipoprotein lipase defiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990;86:735-750.
54. Syvänne M, Antikainen M, Ehnholm S et al. Heterozygosity for Asn291Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res 1996;37:727-738.
55. Fisher RM, Mailly F, Peacock RE et al. Interaction of the lipoprotein lipase Asn291 → Ser mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidaemic subjects, myocardial infarction survivors and healthy controls. J Lipid Res 1995;36:2112.
56. Gehrisch S, Tesche R, Kostka H, Julius U, Jaross W. Point mutations in the hepatic triglyceride lipase (HTGL) gene in familial combined hyperlipidemia (FCHL). Circulation 1995;92(Suppl);2352 (Abstract).
57. Tikkanen MJ, Nikkilä EA. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J 1987;113:562-567.
58. Breckenbridge WC, Little JA, Alapouvic P et al. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982;45:161.
59. Connelly PW, Maguire GF, Lee M, Little JA. Plasma lipoproteins in familial heparic lipase deficiency. Arteriosclerosis 1990;10:40-48.
60. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and the development of ischemic heart disease. Lancet 1975;1:16-19.
61. Ballantyne FC, Clark FS, Simpson HS, Ballantyne D. High density lipoprotein and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982;31:433-437.
62. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso Heart Study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977;1:965-968.
63. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707.
64. Sultan F, Lagrange D, Le Liepvre X, Griglio S. Chylomicronremnant uptake by freshly isolated hepatocytes: effect of heparin and of hepatic triacylglycerol lipase. Biochem J 1989;258:587-594.
65. Sultan F, Lagrange D, Jansen H, Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim Biophys Acta 1990;1042:150-152.
66. Applebaum-Bowden D. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 1995;6:130-135.